A BILL 
To amend the Controlled Substances Act to provide for the 
modification, transfer, and termination of a registration 
to manufacture, distribute, or dispense controlled sub-
stances or list I chemicals, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Ensuring Compliance 
4
Against Drug Diversion Act of 2021’’. 
5
01:07 Mar 17, 2021
H1899
2 
•HR 1899 IH
SEC. 2. MODIFICATION, TRANSFER, AND TERMINATION OF 
1
REGISTRATION 
TO 
MANUFACTURE, 
DIS-
2
TRIBUTE, OR DISPENSE CONTROLLED SUB-
3
STANCES. 
4
Subsection (a) of section 302 of the Controlled Sub-
5
stances Act (21 U.S.C. 822) is amended by adding at the 
6
end the following new paragraph: 
7
‘‘(3)(A) Except as provided in subparagraph (C), the 
8
registration of any registrant under this title to manufac-
9
ture, distribute, or dispense controlled substances or list 
10
I chemicals terminates if and when such registrant— 
11
‘‘(i) dies; 
12
‘‘(ii) ceases legal existence; 
13
‘‘(iii) discontinues business or professional prac-
14
tice; or 
15
‘‘(iv) surrenders such registration. 
16
‘‘(B) In the case of such a registrant who ceases legal 
17
existence or discontinues business or professional practice, 
18
such registrant shall promptly notify the Attorney General 
19
in writing of such fact. 
20
‘‘(C) No registration under this title to manufacture, 
21
distribute, or dispense controlled substances or list I 
22
chemicals, and no authority conferred thereby, may be as-
23
signed or otherwise transferred except upon such condi-
24
tions as the Attorney General may specify and then only 
25
pursuant to written consent. A registrant to whom a reg-
26
01:07 Mar 17, 2021
H1899
3 
•HR 1899 IH
istration is assigned or transferred pursuant to the pre-
1
ceding sentence may not manufacture, distribute, or dis-
2
pense controlled substances or list I chemicals pursuant 
3
to such registration until the Attorney General receives 
4
such written consent. 
5
‘‘(D) In the case of a registrant under this title to 
6
manufacture, distribute, or dispense controlled substances 
7
or list I chemicals desiring to discontinue business or pro-
8
fessional practice altogether or with respect to controlled 
9
substances and list I chemicals (without assigning or 
10
transferring such business or professional practice to an-
11
other entity), such registrant shall return to the Attorney 
12
General for cancellation— 
13
‘‘(i) the registrant’s certificate of registration; 
14
‘‘(ii) any unexecuted order forms in the reg-
15
istrant’s possession; and 
16
‘‘(iii) any other documentation that the Attor-
17
ney General may require.’’. 
18
SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. 
19
The budgetary effects of this Act, for the purpose of 
20
complying with the Statutory Pay-As-You-Go Act of 2010, 
21
shall be determined by reference to the latest statement 
22
titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this 
23
Act, submitted for printing in the Congressional Record 
24
by the Chairman of the House Budget Committee, pro-
25
01:07 Mar 17, 2021
H1899
4 
•HR 1899 IH
vided that such statement has been submitted prior to the 
1
vote on passage. 
2
Æ 
01:07 Mar 17, 2021
H1899
